BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36828801)

  • 1. Emerging nanoparticle designs against bacterial infections.
    Zhou Z; Kai M; Wang S; Wang D; Peng Y; Yu Y; Gao W; Zhang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(4):e1881. PubMed ID: 36828801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle approaches against bacterial infections.
    Gao W; Thamphiwatana S; Angsantikul P; Zhang L
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(6):532-47. PubMed ID: 25044325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell membrane-coated nanoparticles for the treatment of bacterial infection.
    Ma J; Jiang L; Liu G
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Sep; 14(5):e1825. PubMed ID: 35725897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface modification of nano-drug delivery systems for enhancing antibiotic delivery and activity.
    Osman N; Devnarain N; Omolo CA; Fasiku V; Jaglal Y; Govender T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jan; 14(1):e1758. PubMed ID: 34643067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimuli-responsive nanoplatforms for antibacterial applications.
    Huang Y; Zou L; Wang J; Jin Q; Ji J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 May; 14(3):e1775. PubMed ID: 35142071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the applications of hyaluronic acid-based nanoparticles for diagnosis and treatment of bacterial infections.
    Mohammed M; Devnarain N; Elhassan E; Govender T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jul; 14(4):e1799. PubMed ID: 35485247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano-therapeutics: A revolution in infection control in post antibiotic era.
    Zaidi S; Misba L; Khan AU
    Nanomedicine; 2017 Oct; 13(7):2281-2301. PubMed ID: 28673854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades.
    Devnarain N; Osman N; Fasiku VO; Makhathini S; Salih M; Ibrahim UH; Govender T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1664. PubMed ID: 32808486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silver nanoparticles as potential antibacterial agents.
    Franci G; Falanga A; Galdiero S; Palomba L; Rai M; Morelli G; Galdiero M
    Molecules; 2015 May; 20(5):8856-74. PubMed ID: 25993417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prospect of Biomimetic Immune Cell Membrane-Coated Nanomedicines for Treatment of Serious Bacterial Infections and Sepsis.
    Hoffman A; Nizet V
    J Pharmacol Exp Ther; 2024 May; 389(3):289-300. PubMed ID: 38580449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging antibacterial nanomedicine for enhanced antibiotic therapy.
    Wang S; Gao Y; Jin Q; Ji J
    Biomater Sci; 2020 Dec; 8(24):6825-6839. PubMed ID: 32996490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intelligent design of polymersomes for antibacterial and anticancer applications.
    Wang T; Qin J; Cheng J; Li C; Du J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Sep; 14(5):e1822. PubMed ID: 35673991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Nanotherapeutics as Next-generation Anti-infective Agents: Current Trends and Future Prospectives.
    Subhaswaraj P; Syed A; Siddhardha B
    Curr Drug Discov Technol; 2020; 17(4):457-468. PubMed ID: 31309893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering hybrid nanosystems for efficient and targeted delivery against bacterial infections.
    Elhassan E; Devnarain N; Mohammed M; Govender T; Omolo CA
    J Control Release; 2022 Nov; 351():598-622. PubMed ID: 36183972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymol-Decorated Gold Nanoparticles for Curing Clinical Infections Caused by Bacteria Resistant to Last-Resort Antibiotics.
    Huang Z; Zhang X; Yao Z; Han Y; Ye J; Zhang Y; Chen L; Shen M; Zhou T
    mSphere; 2023 Jun; 8(3):e0054922. PubMed ID: 37017551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle formulations for therapeutic delivery, pathogen imaging and theranostic applications in bacterial infections.
    Jiang L; Ding L; Liu G
    Theranostics; 2023; 13(5):1545-1570. PubMed ID: 37056563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-Based Therapies for Wound Biofilm Infection: Opportunities and Challenges.
    Kim MH
    IEEE Trans Nanobioscience; 2016 Apr; 15(3):294-304. PubMed ID: 26955044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomaterials with active targeting as advanced antimicrobials.
    Smerkova K; Dolezelikova K; Bozdechova L; Heger Z; Zurek L; Adam V
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1636. PubMed ID: 32363802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicine and infectious diseases.
    Bragg RR; Kock L
    Expert Rev Anti Infect Ther; 2013 Apr; 11(4):359-61. PubMed ID: 23566145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomimetic Nanotechnology toward Personalized Vaccines.
    Zhou J; Kroll AV; Holay M; Fang RH; Zhang L
    Adv Mater; 2020 Apr; 32(13):e1901255. PubMed ID: 31206841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.